ABCAM Plc Director's Dealings (3915V)
28 October 2014 - 1:31AM
UK Regulatory
TIDMABC
RNS Number : 3915V
ABCAM Plc
27 October 2014
For immediate release 27 October 2014
ABCAM PLC
("Abcam" or "the Company")
Directors' dealing: Share Incentive Plan
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the
supply of life science research tools, has today been notified of
the following transactions to the benefit of Executive Directors,
arising from the annual invitation to all UK based employees to
participate in the Abcam plc Share Incentive Plan:
Name Partnership Matching Free Shares
Shares purchased Shares granted awarded on
on 24 October on 24 October 24 October
2014 at 398p 2014 at 398p 2014 at 398p
per 0.2 pence per 0.2 pence per 0.2 pence
Ordinary Share Ordinary Ordinary Share
Share
Alan Hirzel 452 452 904
------------------ ---------------- ----------------
Jim Warwick 452 452 904
------------------ ---------------- ----------------
Jeff Iliffe 452 452 904
------------------ ---------------- ----------------
The risk of forfeiture attached to the Matching Shares will
normally be removed on the third anniversary of the award subject
to continued employment and the retention of the Partnership Shares
in connection with which they were awarded. The risk of forfeiture
attached to the Free Shares will normally be removed on the third
anniversary of the award subject to continued employment.
No consideration was paid by the above grantees for the award of
the Matching and Free Shares and no consideration is due on the
release of these shares.
For further information please contact:
Abcam + 44 (0) 1223 696 000
Alan Hirzel / Jeff Iliffe
Numis Securities - Nominated Adviser
and Joint Broker + 44 (0) 20 7260 1000
Michael Meade - Nominated Adviser
James Black - Corporate Broking
Peel Hunt LLP - Joint Broker + 44 (0) 20 7418 8900
Clare Terlouw / Jock Maxwell MacDonald
- Corporate Broking
Brunswick + 44 (0) 20 7404 5959
Justine Mcllroy / Robin Wrench / Emma
Walsh
Notes for editors:
About Abcam plc
Abcam plc is a leading provider of protein research tools and
services, with a wide range of products and expert technical
support, enabling scientists to analyse living cells at the
molecular level and improving the understanding of health and
disease.
Abcam is committed to providing scientists with an extensive
choice of reagents and tools, with the most comprehensive, honest
and up-to-date datasheets and customer reviews, fast delivery and
helpful customer service & technical support. The Company's
catalogue evolves with scientific research trends and is growing
each year to provide customers with products to meet their research
needs. The range now includes primary and secondary antibodies,
proteins, peptides, lysates, biochemicals, immunoassays and other
kits. Abcam also supports its customers by hosting a range of
global scientific events, forums and webinars, providing
opportunities for scientists to get together and present their
work.
Headquartered in Cambridge, UK, Abcam has eight global
subsidiary offices enabling local services, multi-language support
sells to over 100 countries. The Company was founded in 1998, and
now employs over 740 people. Abcam was admitted to AIM in 2005
(AIM: ABC).
To find out more, please visit www.abcam.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSPGGUWUUPCGCM
Abcam (LSE:ABC)
Historical Stock Chart
From Apr 2024 to May 2024
Abcam (LSE:ABC)
Historical Stock Chart
From May 2023 to May 2024